Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The guideline provides recommendations for managing alopecia areata effectively.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Significant hair regrowth doesn't always mean complete hair recovery in alopecia areata.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

rwSALT provides precise hair regrowth measurement from scalp photos.

rwSALT accurately measures hair regrowth in alopecia areata using scalp photos.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Low vitamin D levels are common in people with Alopecia Areata.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Baricitinib is effective and safe for treating severe alopecia areata.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

AI can accurately measure hair loss severity in alopecia areata.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

AB+ blood group is more common in alopecia areata patients.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Oral Apremilast effectively treats alopecia areata in most patients.

Liquid nitrogen cryotherapy is an effective treatment for alopecia areata.

Men can have genetic risks for PCOS-related traits like obesity and diabetes.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.